Recent Product Approvals Elanco received Emergency Use Authorization from the FDA for Credelio to treat New World screwworm infestations in dogs, indicating opportunities to promote and expand usage of this innovative parasitic treatment across veterinary clinics and pet owners.

Market Expansion Efforts With Elanco expanding its R&D and office footprint in Indianapolis while planning to close its German facility, there is potential to upsell research services, collaborate on new product development, and support regional market growth.

Social Responsibility Engagement Elanco's campaigns like National Parvo Awareness Day and partnerships for hunger relief demonstrate a strong commitment to community and animal health initiatives, presenting opportunities to align with corporate social responsibility programs and targeted outreach initiatives.

Innovation and Technology Adoption Elanco leverages advanced tech platforms such as Kubernetes, SAP Ariba, and Workday, which could open doors for offering complementary digital solutions, integration services, or tech partnerships that enhance operational efficiencies.

Financial and Legal Developments Recent legal challenges related to securities fraud and breach of fiduciary duty may influence current decision-making and risk assessments, making it crucial to approach potential clients with tailored solutions that address compliance, data integrity, and transparency concerns.